Pharmacyte Biotech, Inc. · NASDAQ:PMCB
Pharmacyte Biotech, Inc. shareholders
As of Jun 30, 2026, 27 institutions reported holding Pharmacyte Biotech, Inc., 7.1% of its shares. Largest: Citadel, Geode Capital and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Pharmacyte Biotech, Inc. | Change | Filed |
|---|---|---|---|---|
| Citadel | 283K | 2.6% | −76,166 | Aug 14, 2026 |
| Geode Capital | 124K | 1.2% | −71,413 | Aug 12, 2026 |
| Vanguard | 80,230 | 0.75% | +5,311 | Aug 13, 2026 |
| Susquehanna | 44,853 | 0.42% | new | Aug 14, 2026 |
| Renaissance Technologies | 37,987 | 0.35% | −18,513 | Aug 13, 2026 |
| XTX Topco Ltd | 34,180 | 0.32% | −18,182 | Aug 14, 2026 |
| Northern Trust | 32,624 | 0.30% | −2,977 | Aug 13, 2026 |
| Jane Street | 30,064 | 0.28% | +18,534 | Aug 14, 2026 |
| Schonfeld Strategic Advisors LLC | 26,926 | 0.25% | −83 | Aug 14, 2026 |
| Equitec Proprietary Markets, LLC | 22,227 | 0.21% | no change | Jul 20, 2026 |